Search
Patexia Research
Case number 337-TA-766

Gemcitabine and Products Containing Same > Summary

Court Case Number 337-TA-766

Filing Date Jan 20, 2011

Docket Number 2780

Investigation Type Violation

Unfair Act Patent Infringement

Institution Date Mar 23, 2011

Markman Hearing Start Date -

Markman Hearing End Date -

Evidentiary Hearing Scheduled Start Date Jan 23, 2012

Evidentiary Hearing Scheduled End Date Feb 3, 2012

Evidentiary Hearing Actual Start Date -

Evidentiary Hearing Actual End Date -

Target Date Jul 23, 2012

Final ID On Violation Due Date Mar 22, 2012

Final ID On Violation Issue Date -

Non Final (Terminating) ID Issued Aug 16, 2011

Final Determination of No Violation -

Final Determination of Violation -

Termination Date Aug 30, 2011

Court International Trade Commission

Status Terminated

Administrative JudgesRobert Rogers

Active JudgeRobert Rogers

Complainant

Eli Lilly and Company

Respondent

5

Hospira

Intas Pharmaceuticals Ltd.

Jiangsu Hansoh Pharmaceutical Group Co. Ltd.

Chemwerth Inc.

Intas Pharmaceuticals Ltd. Gujarat

Complainant Attorneys

21

Eli Lilly and Company
Attorney Name: Robert Schaffer
Finnegan, Henderson, Farabow, Garrett & Dunner

Eli Lilly and Company
Attorney Name: Robert F. McCauley III
Finnegan, Henderson, Farabow, Garrett & Dunner

Eli Lilly and Company
Attorney Name: Charles E. Lipsey
Finnegan, Henderson, Farabow, Garrett & Dunner

Eli Lilly and Company
Attorney Name: Phillip K. Decker
Finnegan, Henderson, Farabow, Garrett & Dunner

Eli Lilly and Company
Attorney Name: Christine M. Hlavka
Finnegan, Henderson, Farabow, Garrett & Dunner

Eli Lilly and Company
Attorney Name: Jennifer S. Swan
Finnegan, Henderson, Farabow, Garrett & Dunner

Eli Lilly and Company
Attorney Name: Rebecca L. Harker
Finnegan, Henderson, Farabow, Garrett & Dunner

Eli Lilly and Company
Attorney Name: Robert D. Bajefsky
Finnegan, Henderson, Farabow, Garrett & Dunner

Eli Lilly and Company
Attorney Name: Ryan James Cudnik
Finnegan, Henderson, Farabow, Garrett & Dunner

Eli Lilly and Company
Attorney Name: Maximilienne Giannelli
Finnegan, Henderson, Farabow, Garrett & Dunner

Eli Lilly and Company
Attorney Name: Shana K. Cyr
Finnegan, Henderson, Farabow, Garrett & Dunner

Eli Lilly and Company
Attorney Name: Akira Irie
Finnegan, Henderson, Farabow, Garrett & Dunner

Eli Lilly and Company
Attorney Name: Daniel In Jea Wong
Finnegan, Henderson, Farabow, Garrett & Dunner

Eli Lilly and Company
Attorney Name: Geert-Jan Boons
Finnegan, Henderson, Farabow, Garrett & Dunner

Eli Lilly and Company
Attorney Name: Paul Reider
Finnegan, Henderson, Farabow, Garrett & Dunner

Eli Lilly and Company
Attorney Name: Mauricio Futran
Finnegan, Henderson, Farabow, Garrett & Dunner

Eli Lilly and Company
Attorney Name: Robert F. Shaffer
Finnegan, Henderson, Farabow, Garrett & Dunner

Eli Lilly and Company
Attorney Name: Michael Yu Zhu
Finnegan, Henderson, Farabow, Garrett & Dunner

Eli Lilly and Company
Attorney Name: Teresa Wong
Tonelee Linguistic Consulting

Eli Lilly and Company
Attorney Name: Krista M. Bianco
Finnegan, Henderson, Farabow, Garrett & Dunner

Eli Lilly and Company
Attorney Name: Albert H. Lyter
Finnegan, Henderson, Farabow, Garrett & Dunner

Respondent Attorneys

33

Hospira
Attorney Name: James F. Hurst
Winston & Strawn

Hospira
Attorney Name: Cyrus Frelinghuysen
Winston & Strawn

Intas Pharmaceuticals Ltd.
Attorney Name: Stephanie L. Elmer
Sterne, Kessler, Goldstein & Fox

Hospira
Attorney Name: Richard J. Basile
St. Onge Steward Johnston & Reens

ChemWerth Inc.
Attorney Name: Bojuan Deng
St. Onge Steward Johnston & Reens

JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD.
Attorney Name: Bojuan Deng
St. Onge Steward Johnston & Reens

Hospira
Attorney Name: Nicholas Short
Winston & Strawn

Hospira
Attorney Name: Ashlea Raymond Pflug
Winston & Strawn

Jiangsu Hansoh
Attorney Name: Richard J. Basile
St. Onge Steward Johnston & Reens

Intas Pharmaceuticals Ltd.
Attorney Name: Nirav N. Desai
Sterne, Kessler, Goldstein & Fox

Hospira
Attorney Name: Laura Katherine Carter
Winston & Strawn

Intas Pharmaceuticals Ltd.
Attorney Name: Suresh B. Pillai
Sterne, Kessler, Goldstein & Fox

Intas Pharmaceuticals Ltd.
Attorney Name: Robert William Esmond
Sterne, Kessler, Goldstein & Fox

Hospira
Attorney Name: Gail J. Standish
Winston & Strawn

Hospira
Attorney Name: Peter E. Perkowski
Winston & Strawn

Hospira
Attorney Name: John K. Hsu
Winston & Strawn

Intas Pharmaceuticals Ltd.
Attorney Name: Colin C. Heitzmann
Sterne, Kessler, Goldstein & Fox

Intas Pharmaceuticals Ltd.
Attorney Name: Jeremiah B. Frueauf
Sterne, Kessler, Goldstein & Fox

Intas Pharmaceuticals Ltd.
Attorney Name: Hemant Keeto Sabharwal
Sterne, Kessler, Goldstein & Fox

Hospira
Attorney Name: Juliette Dean
Winston & Strawn

Hospira
Attorney Name: Jovial Wong
Winston & Strawn

Hospira
Attorney Name: Patricia Giebink
Winston & Strawn

Hospira
Attorney Name: Erich J. Speckin
Winston & Strawn

Hospira
Attorney Name: Michael M. Murray
Winston & Strawn

Hospira
Attorney Name: Neal G. Anderson
Winston & Strawn

Hospira
Attorney Name: Robert M. Adlington
Winston & Strawn

Hospira
Attorney Name: Christopher M. Bruno
Winston & Strawn

ChemWerth Inc.
Attorney Name: Richard J. Basile
St. Onge Steward Johnston & Reens

JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD.
Attorney Name: Richard J. Basile
St. Onge Steward Johnston & Reens

ChemWerth Inc.
Attorney Name: Gene S. Winter
St. Onge Steward Johnston & Reens

JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD.
Attorney Name: Gene S. Winter
St. Onge Steward Johnston & Reens

Intas Pharmaceuticals Ltd.
Attorney Name: Daniel E. Yonan
Sterne, Kessler, Goldstein & Fox

The Upjohn Company
Attorney Name: Daniel E. Yonan
Sterne, Kessler, Goldstein & Fox

Related Patents

Doc No Title Issue date
05606048 Stereoselective glycosylation process for preparing 2'-Deoxy-2', 2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides Feb 25, 1997
Menu